PsyBio Therapeutics PSYBF Stock
PsyBio Therapeutics Price Chart
PsyBio Therapeutics PSYBF Financial and Trading Overview
| PsyBio Therapeutics stock price | 0.0079 USD |
| Previous Close | 0.01 USD |
| Open | 0.02 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.15 USD |
| Volume | 90 USD |
| Avg. Volume | 26.36K USD |
| Market Cap | 3.91M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PSYBF Valuation Measures
| Enterprise Value | 1.98M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
PsyBio Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -63.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.05 USD |
PSYBF Share Statistics
| Avg. Volume (3 month) | 26.36K USD |
| Avg. Daily Volume (10-Days) | 28.7K USD |
| Shares Outstanding | 83.93M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 19.84% |
| % Held by Institutions | 10.25% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of PsyBio Therapeutics
| Country | United States |
| State | CO |
| City | Denver |
| Address | 1624 Washington Street |
| ZIP | 80203 |
| Phone | 513 449 9585 |
| Website | https://www.psybiolife.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.
Q&A For PsyBio Therapeutics Stock
What is a current PSYBF stock price?
PsyBio Therapeutics PSYBF stock price today per share is 0.0079 USD.
How to purchase PsyBio Therapeutics stock?
You can buy PSYBF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PsyBio Therapeutics?
The stock symbol or ticker of PsyBio Therapeutics is PSYBF.
Which industry does the PsyBio Therapeutics company belong to?
The PsyBio Therapeutics industry is Biotechnology.
How many shares does PsyBio Therapeutics have in circulation?
The max supply of PsyBio Therapeutics shares is 119.38M.
What is PsyBio Therapeutics Price to Earnings Ratio (PE Ratio)?
PsyBio Therapeutics PE Ratio is now.
What was PsyBio Therapeutics earnings per share over the trailing 12 months (TTM)?
PsyBio Therapeutics EPS is -0.02 USD over the trailing 12 months.
Which sector does the PsyBio Therapeutics company belong to?
The PsyBio Therapeutics sector is Healthcare.